Pharmaceutical Preparations · CIK 1520262
Alkermes plc develops and commercializes medicines for diseases of the central nervous system and oncology
Comparable business profile · signals at a glance
In the 90 days to Mar 3, 2026: 5 sold $3.6M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 3, 2026 | Gaffin David JosephEVP, CLO, Alkermes, Inc. | Sell | 2,034 | $29.76 | $61K |
| Mar 2, 2026 | Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sell | 9,000 | $29.72 | $267K |
| Mar 2, 2026 | Parisi Samuel JosephVP, Finance (Interim PAO) | Sell | 6,890 | $29.29 | $202K |
| Mar 2, 2026 | Nichols Christian ToddSVP, Chief Commercial Officer | Sell | 6,000 | $30.00 | $180K |
| Mar 2, 2026 | Gaffin David JosephEVP, CLO, Alkermes, Inc. | Sell | 2,034 | $29.29 | $60K |
| Feb 2, 2026 | Cooke ShaneDirector | Sell | 32,113 | $34.78 | $1.1M |
| Feb 2, 2026 | Cooke ShaneDirector | Sell | 29,087 | $34.34 | $999K |
| Feb 2, 2026 | Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sell | 5,000 | $34.24 | $171K |
| Feb 2, 2026 | Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sell | 4,000 | $33.54 | $134K |
| Jan 8, 2026 | Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sell | 5,000 | $30.00 | $150K |
| Jan 2, 2026 | Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sell | 4,000 | $28.00 | $112K |
| Dec 3, 2025 | Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sell | 3,748 | $30.00 | $112K |
| Dec 1, 2025 | Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sell | 4,000 | $29.30 | $117K |
| Nov 3, 2025 | Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sell | 9,000 | $30.38 | $273K |
| Oct 15, 2025 | Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sell | 9,000 | $31.53 | $284K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.